Bionano genomics news.
We believe this technology-centric view is holding us back from the answers to critical questions around the origin, diagnosis, severity and treatment of cancer and genetic disease. We believe the way to move forward is an inclusive one that reveals what other tools miss and unifies data across technologies into one view to maximize the ...
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that optical genome mapping (OGM) was included for the first time in Thompson and Thompson... Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 Globe Newswire • 26 days ago. Aug 30, 2023 · SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication in Nature Communications demonstrating the utility of optical genome mapping (OGM) as an alternative to karyotyping (KT) and chromosomal microarray (CMA) for the evaluation of CRISPR-Cas9 edited human induced pluripotent stem cell (iPSC) lines in order to uncover possible pathogenic ... Over the past 30 days, the shares of Bionano Genomics Inc (NASDAQ:BNGO) have changed 24.81%. Short interest in the company has seen 7.08 million shares shorted with days to cover at 6.06. Wall Street analysts have a consensus price target for the stock at $12.33, which means that the shares’ value could jump …Bionano Announces Results from its Annual Meeting of Stockholders. SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its stockholders approved all proposals set forth at its 2023 Annual Meeting, held earlier today. The final voting results will be available in a current report on Form 8-K, which ...
Apr 13, 2023 · The current analyst consensus has Bionano Genomics, Inc. losing around 45 cents a share in FY2023 as sales rise nearly 30% to $35.7 million. Revenue growth is projected to accelerate by over 70% ... About Bionano Genomics. Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.The market for genomics products and services is significant, expected to grow at a CAGR of 10.2% from 2017-2022, reaching $23.9 billion by 2022. Bionano is targeting two types of end users. First ...
Q4 revenue was $8.2 million, which represents a 30% increase over Q4 2021; 2022 revenue was $27.8 million, which represents a 55% increase over year end 2021; Reached installed base of 240 Saphyr® systems as of YE 2022, which represents a 46% increase over YE 2021; Conference call today, March 9 th, 2023 at 4:30 PM ET SAN …
4 Agu 2023 ... Bionano Genomics, Inc. (BNGO) will effect a one-for-ten (1-10) ... Nasdaq offers customers the ability to self select news delivery across various ...Mar 7, 2023 · Bionano Genomics. Market Cap. $61M. Today's Change. (4.64%) $0.07. Current Price. $1.58. Price as of November 29, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ ... Aug 7, 2023 · Bionano Genomics (NASDAQ: BNGO) effected a 1-for-10 reverse stock split and announced that it will publish quarterly earnings on Aug. 9. Shares opened this morning at $4.73 each, a market ... SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, May 9, 2023, at 4:30 p.m. Eastern ...
Bionano Genomics, Inc. (NASDAQ: BNGO) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming ...
News Release Details « Back. Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2022 Results. Jan 05, 2023 | PDF Version - Preliminary Q4 revenue expected to be between $8.1 and $8.4 million; 29% to 33% increase over Q4 2021 - Reached installed base of 240 systems as of YE 2022; 46% increase over YE 2021 ...
Get the latest Bionano Genomics, Inc. (BNGO) stock news and headlines to help you in your trading and investing decisions.About Bionano Genomics. Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.Sep 21, 2023 · SAN DIEGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that its Chinese OEM partner, Ecobono, a distribution company focused on reproductive health products, has obtained reagent Class I registration from China's NMPA for Bionano's DNA isolation products. Ecobono is Bionano’s third Chinese OEM ... BNGO Bionano Genomics Inc. 1.65. 0.21 ( 14.58% ) Nov 24 2023 - Closed. Delayed by 15 minutes. 10 Sec. Barclays: High Bar For The Dollar. Quote. Chart.News Releases. Year. 2023. 14 Nov '23. Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual …
News. Press Releases. Research Reports. ... Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2023 Earnings Call Transcript November 8, 2023 Bionano Genomics, Inc. misses on earnings expectations. Reported ... Find the latest Bionano Genomics, Inc. (BNGO) stock quote, history, news and other vital information to help you with your stock trading and investing. Sep 30, 2021 · – Acquisition of BioDiscove ry transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics – Total revenue of $4.7 million , a 112% year-over-year total revenue increase, driven by Bionano Genomics, Inc. +1 (858) 888-7610. [email protected]. Investor Relations: Amy Conrad. Juniper Point. +1 (858) 366-3243. [email protected]. Bionano CEO and president Dr. Erik Holmlin ...Bionano Genomics, Inc. misses on earnings expectations. Reported EPS is $-1 EPS, expectations were $-0.75. Operator: Good day, and welcome to the Bionano’s Third Quarter 2023 Earnings Conference ...
SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication from researchers at the German Cancer Consortium (DKTK) showing the utility of optical genome mapping (OGM) and whole-exome sequencing (WES) in better understanding the mutational landscape of …Study Shows that OGM Plays an Important Role in Efficient Diagnosis of FSHD. SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories …
A-smart is Bionano’s second Chinese OEM partner to obtain approval from NMPA for the Company’s optical genome mapping (OGM) solutions. NMPA issued two approvals to A-smart: one for Bionano’s G2 direct label and stain (DLS) DNA labeling kit and one for Bionano’s G2 SP bone marrow aspirate (BMA) DNA isolation kit.Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting. Find the latest …Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...4 Agu 2023 ... Bionano Genomics, Inc. (BNGO) will effect a one-for-ten (1-10) ... Nasdaq offers customers the ability to self select news delivery across various ...News Release Details « Back. Bionano Genomics Reports Second Quarter 2022 Financial Results and Highlights Recent Business Progress. Aug 04, 2022 | PDF …Bionano Genomics' $2.1 million in cash in SVB accounts is part of $113.2 million in cash, cash equivalents and AFS securities. MarketWatch Mar 13, 2023 7:41am.Feb 9, 2023 · About Bionano Genomics Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. Track Bionano Genomics Inc (BNGO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBionano Reports First Quarter 2023 Results and Highlights Recent Business Progress. Q1 2023 revenue was $7.4 million, which represents a 30% increase over Q1 2022. Installed base of 259 Saphyr ...Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting. Find the latest …
News Release Details « Back. Bionano Genomics Reports First Quarter 2022 Financial Results and Highlights Recent Business Progress. May 05, 2022 | PDF Version - 80% year-over-year revenue growth in Q1 2022 - Achieved all Q1 2022 ELEVATE! milestones - Strong balance sheet with $216.5 million in cash, cash equivalents, and …
SAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the launch of Bionano Laboratories, a new organization that combines Bionano’s optical genome mapping (OGM) data services with the clinical testing services previously offered by Lineagen, and the launch of Bionano Laboratories’ first OGM-based laboratory developed test (LDT).
Q4 revenue was $8.2 million, which represents a 30% increase over Q4 2021; 2022 revenue was $27.8 million, which represents a 55% increase over year end 2021; Reached installed base of 240 Saphyr® systems as of YE 2022, which represents a 46% increase over YE 2021; Conference call today, March 9 th, 2023 at 4:30 PM ET SAN …11 Jul 2023 ... BNGO stock is receiving lots of attention from retail investors, some who claim Bionano Genomics stock ... BREAKING NEWS - Bionano CFO Reveals Why ...Company Contact: Erik Holmlin, CEO. Bionano Genomics, Inc. +1 (858) 888-7610. [email protected]. Investor Relations: +1 (858) 888-7625. [email protected]. Three peer-reviewed publications ...Bionano Genomics (NASDAQ:BNGO) effected a 1-for-10 reverse stock split and announced that it will publish quarterly earnings on Aug. 9. Shares opened this morning at $4.73 each, a market ...News Release Details « Back. Bionano Genomics Reports First Quarter 2022 Financial Results and Highlights Recent Business Progress. May 05, 2022 | PDF Version - 80% year-over-year revenue growth in Q1 2022 - Achieved all Q1 2022 ELEVATE! milestones - Strong balance sheet with $216.5 million in cash, cash equivalents, and …News Release Details « Back. Bionano Announces China NMPA Approval for DNA Extraction and Labeling Products for IVD Use in Hematologic Malignancies. Feb 22, 2023 | PDF Version. ... About Bionano Genomics. Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers …Bionano Genomics, Inc. +1 (858) 888-7610. [email protected]. Investor Relations: Amy Conrad. Juniper Point. +1 (858) 366-3243. [email protected]. Bionano CEO and president Dr. Erik Holmlin ...Jun 30, 2023 · Bionano participated at key cytogenetic conferences, including the European Hematology Association (EHA) 2023 Congress, the European Human Genetics (ESHG) 2023 Conference, the European Association for Cancer Research (EACR) 2023 Congress and the International Society for Stem Cell Research (ISSCR) Annual Meeting 2023. OGM was featured in 37 ... The average price point forecasted by analysts for Bionano Genomics Inc (BNGO) is $12.33, which is $10.7 above the current market price. The public float for BNGO is 38.09M, and currently, short sellers hold a 17.35% ratio of that float. The average trading volume of BNGO on November 27, 2023 was 888.80K shares. Top 5 EV Tech Stocks to …
Bionano Genomics, Inc. (NASDAQ: BNGO) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming ...Recent News & Activity. ... Bionano Genomics' Saphyr system uses a technology called optical genome mapping (OGM) to analyze long DNA molecules. OGM allows for the direct visualization and analysis of structural variations in the genome without the need for sequencing. This technology can provide valuable insights into the structural variations in …Jun 14, 2023 · Bionano Announces Results from its Annual Meeting of Stockholders. SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its stockholders approved all proposals set forth at its 2023 Annual Meeting, held earlier today. The final voting results will be available in a current report on Form 8-K, which ... Jun 13, 2023 · SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the International Society for Stem Cell Research (ISSCR) Annual Meeting 2023 with a broad range of content covering the utility of optical genome mapping (OGM) for research, development, and manufacturing applications in stem ... Instagram:https://instagram. amba stock symbolenph stock priceinstacart ipo tickerwhen do iphone 15 preorders start Jun 14, 2023 · Bionano Announces Results from its Annual Meeting of Stockholders. SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its stockholders approved all proposals set forth at its 2023 Annual Meeting, held earlier today. The final voting results will be available in a current report on Form 8-K, which ... e.l.f. stocksphb stock SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 9, 2023, at 4:30 p.m ... inverse etfs to buy SAN DIEGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication demonstrating the use of optical genome mapping (OGM) to identify structural variations (SVs) introduced by CRISPR-Cas9 gene editing of CD4+ T-cells that could potentially limit the therapeutic use of such edited cells.. The …Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform ...Albino parakeets are those that exhibit a mutation in the color-producing portion of their genome. The gene that causes the mutation is called the ino gene. However, because there are two different basic colorations for parakeets—blue and...